ZN-A-1041 was designed to be blood-brain-barrier-penetrant, and has the potential to treat or prevent the onset of brain metastases in patients with HER2-positive metastatic breast cancer
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
Pheezee is designed to assess musculoskeletal and neuromuscular health.
The receipt of this permission paves way for the launch of Trastuzumab deruxtecan (Enhertu) solution of 100mg/5mL in India
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
The company will submit its comprehensive response on these observations to the US FDA within the stipulated time
Subscribe To Our Newsletter & Stay Updated
